The conference covered the full spectrum, from cultivation and manufacturing to products and patients, and highlighted innovations in research, compliance, regulations, education, and technology.
Our participation builds on the foundations established through the MedAg Hub, where our team has been advancing research in medicinal cannabis. With the establishment of the new PC Hub, we will continue this important work with renewed focus and expanded capacity.
Through this initiative, we aim to generate a wide-reaching impact both in Australia and globally. By positioning Australia at the forefront of agribiotech research, production, and manufacturing, the Hub will play a pivotal role in developing an export-ready, commercially competitive medicinal agriculture industry — one that delivers immediate economic benefits while driving scientific and medical progress.
Now in its sixth year and hosted annually by Medicinal Cannabis Industry Australia (MCIA), ACannabis brings together participants from across the entire medicinal cannabis ecosystem — including policymakers, regulators, researchers, global leaders, healthcare professionals, patients, and industry participants.
Stay tuned for updates on our research, industry collaborations, and opportunities to engage with the PC Hub.
🔗 Follow us on LinkedIn to stay connected!
